Vindeløv L L, Hansen H H, Christensen I J, Spang-Thomsen M, Hirsch F R, Hansen M, Nissen N I
Cancer Res. 1980 Nov;40(11):4295-300.
Flow-cytometric DNA analysis yields information on ploidy and proliferative characteristics of a cell population. The analysis was implemented on small-cell anaplastic carcinoma of the lung using a rapid detergent technique for the preparation of fine-needle aspirates for DNA determination and a newly developed procedure for storing aspirates at -80 degrees. Thirty-eight different metastases in 30 consecutive patients with small-cell anaplastic carcinoma of the lung were examined with a total of 273 fine-needle aspirations. The results on ploidy are reported in this paper. The degree of contamination of the aspirates with normal cells was determined by differential counts. The ratio of the peak channel numbers for the G1 phase of the tumor cells to that of the diploid standard (DNA index) was calculated and used for ploidy identification. Twenty-nine patients were evaluable with respect to DNA index determination. The coefficient of variation of the DNA index determinations was estimated as 0.039. In 23 (79%) patients, only one cell line could be detected. Evidence of the presence of 2 tumor cell clones with different ploidy was obtained in the remaining 6 (21%) patients. Of the 35 malignant clones thus demonstrated, 26 (74%) were significantly different from diploid (p less than or equal to 0.01). Four (11%) were hypodiploid, 3 (9%) were hypotriploid, and 19 (54%) were hypo- or near-tetraploid. Clonal heterogeneity in the tumors of 21% of the patients is a conservative estimate. Assessment of the detection limit set by the methodology used and the restricted number of samples studied in each patient indicate that the true occurrence of clonal heterogeneity in small-cell carcinoma of the lung may be much higher.
流式细胞术DNA分析可提供有关细胞群体倍性和增殖特征的信息。该分析通过一种快速去污剂技术在肺小细胞间变性癌上进行,该技术用于制备用于DNA测定的细针穿刺物,以及一种新开发的将穿刺物储存在-80摄氏度的程序。对30例连续的肺小细胞间变性癌患者的38个不同转移灶进行了检查,共进行了273次细针穿刺。本文报告了倍性结果。通过差异计数确定穿刺物中正常细胞的污染程度。计算肿瘤细胞G1期的峰值通道数与二倍体标准(DNA指数)的比值,并用于倍性鉴定。29例患者可进行DNA指数测定。DNA指数测定的变异系数估计为0.039。在23例(79%)患者中,只能检测到一个细胞系。在其余6例(21%)患者中获得了存在两种不同倍性肿瘤细胞克隆的证据。在如此显示的35个恶性克隆中,26个(74%)与二倍体有显著差异(p小于或等于0.01)。4个(11%)为亚二倍体,3个(9%)为亚三倍体,19个(54%)为亚四倍体或近四倍体。21%患者肿瘤中的克隆异质性是一个保守估计。对所用方法设定的检测限以及每个患者研究的样本数量有限的评估表明,肺小细胞癌中克隆异质性的真实发生率可能要高得多。